Header Logo

Connection

Robert Wild to Middle Aged

Back to Details
This is a "connection" page, showing publications Robert Wild has written about Middle Aged.
Robert Wild
Connection Strength
0.824
Middle Aged
  1. Cardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative. Menopause. 2021 05 03; 28(6):610-618.
    View in: PubMed
    Score: 0.085
  2. Clinical intervention to reduce central obesity and menopausal symptoms in women aged 35 to 55 years. Menopause. 2014 Sep; 21(9):975-81.
    View in: PubMed
    Score: 0.053
  3. Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause. 2013 Mar; 20(3):254-60.
    View in: PubMed
    Score: 0.048
  4. Does age affect visualization of the levator ani in nulliparous women? Int Urogynecol J. 2013 Sep; 24(9):1507-13.
    View in: PubMed
    Score: 0.048
  5. Randomized trial comparing office flexible to rigid cystoscopy in women. Int Urogynecol J. 2012 Nov; 23(11):1625-30.
    View in: PubMed
    Score: 0.046
  6. Pioglitazone and metformin for increased small low-density lipoprotein in polycystic ovary syndrome: counterpoint. Am J Obstet Gynecol. 2008 Jan; 198(1):4-6.
    View in: PubMed
    Score: 0.034
  7. Intergenerational Occurrence of Premature Birth and Reproductive Health in Prematurely-Born Women in the Women's Health Initiative. Matern Child Health J. 2024 Oct; 28(10):1793-1811.
    View in: PubMed
    Score: 0.027
  8. The association between reproductive history and abdominal adipose tissue among postmenopausal women: results from the Women's Health Initiative. Hum Reprod. 2024 Aug 01; 39(8):1804-1815.
    View in: PubMed
    Score: 0.027
  9. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003 Mar; 88(3):1048-54.
    View in: PubMed
    Score: 0.024
  10. The association of hormone therapy with blood pressure control in postmenopausal women with hypertension: a secondary analysis of the Women's Health Initiative clinical trials. Menopause. 2023 01 01; 30(1):28-36.
    View in: PubMed
    Score: 0.023
  11. Adverse Pregnancy Outcomes and Incident Heart Failure in the Women's Health Initiative. JAMA Netw Open. 2021 12 01; 4(12):e2138071.
    View in: PubMed
    Score: 0.022
  12. Recreational Physical Activity, Sitting, and Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):97-107.
    View in: PubMed
    Score: 0.022
  13. Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2021 11; 30(11):2018-2029.
    View in: PubMed
    Score: 0.022
  14. Androgens and syndrome X. Menopause. 2001 Jul-Aug; 8(4):229.
    View in: PubMed
    Score: 0.021
  15. Dietary cholesterol and egg intake in relation to incident cardiovascular disease and all-cause and cause-specific mortality in postmenopausal women. Am J Clin Nutr. 2021 04 06; 113(4):948-959.
    View in: PubMed
    Score: 0.021
  16. The severity of vasomotor symptoms and number of menopausal symptoms in postmenopausal women and select clinical health outcomes in the Women's Health Initiative Calcium and Vitamin D randomized clinical trial. Menopause. 2020 11; 27(11):1265-1273.
    View in: PubMed
    Score: 0.020
  17. The association between weight-promoting medication use and weight gain in postmenopausal women: findings from the Women's Health Initiative. Menopause. 2020 10; 27(10):1117-1125.
    View in: PubMed
    Score: 0.020
  18. Walking Volume and Speed Are Inversely Associated With Incidence of Treated Hypertension in Postmenopausal Women. Hypertension. 2020 11; 76(5):1435-1443.
    View in: PubMed
    Score: 0.020
  19. Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative. J Vasc Surg. 2021 04; 73(4):1245-1252.e3.
    View in: PubMed
    Score: 0.020
  20. Feasibility and Utility of a Cardiovascular Risk Screening Tool in Women Undergoing Routine Gynecology Evaluation. J Womens Health (Larchmt). 2020 09; 29(9):1150-1159.
    View in: PubMed
    Score: 0.020
  21. The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
    View in: PubMed
    Score: 0.019
  22. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019 09 07; 40(34):2849-2855.
    View in: PubMed
    Score: 0.019
  23. Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study. Cancer Causes Control. 2019 Apr; 30(4):355-363.
    View in: PubMed
    Score: 0.018
  24. Risk factors: assessment and preventive measures. Clin Obstet Gynecol. 1998 Dec; 41(4):966-75.
    View in: PubMed
    Score: 0.018
  25. Lipids and Women's Health: Recent Updates and Implications for Practice. J Womens Health (Larchmt). 2019 06; 28(6):752-760.
    View in: PubMed
    Score: 0.017
  26. Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016 Jul-Aug; 10(4):833-841.
    View in: PubMed
    Score: 0.015
  27. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. J Clin Lipidol. 2015 Nov-Dec; 9(6 Suppl):S1-122.e1.
    View in: PubMed
    Score: 0.014
  28. Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity. Am J Obstet Gynecol. 1992 Dec; 167(6):1813-8.
    View in: PubMed
    Score: 0.012
  29. Autoantibodies associated with endometriosis: can their detection predict presence of the disease? Obstet Gynecol. 1991 Jun; 77(6):927-31.
    View in: PubMed
    Score: 0.011
  30. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study. Clin Endocrinol (Oxf). 2011 Jan; 74(1):89-96.
    View in: PubMed
    Score: 0.010
  31. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril. 1990 Aug; 54(2):255-9.
    View in: PubMed
    Score: 0.010
  32. Lipoprotein lipids in women with androgen excess: independent associations with increased insulin and androgen. Clin Chem. 1990 Feb; 36(2):283-9.
    View in: PubMed
    Score: 0.010
  33. Hysterectomy prevalence and cardiovascular disease risk factors in American Indian women. Maturitas. 2005 Nov-Dec; 52(3-4):328-36.
    View in: PubMed
    Score: 0.007
  34. Associations of postmenopausal hormone therapy with markers of hemostasis and inflammation and lipid profiles in diabetic and nondiabetic american Indian women: the strong heart study. J Womens Health (Larchmt). 2004 Mar; 13(2):155-63.
    View in: PubMed
    Score: 0.006
  35. The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2000 Jan; 85(1):214-8.
    View in: PubMed
    Score: 0.005
  36. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 1998 May 13; 279(18):1445-51.
    View in: PubMed
    Score: 0.004
  37. Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group. Obstet Gynecol. 1994 Dec; 84(6):987-95.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.